Australia markets open in 9 hours 22 minutes

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1050-0.0150 (-0.71%)
As of 10:35AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.1200
Open2.1200
Bid2.0900 x 1000
Ask2.1100 x 1200
Day's range2.0800 - 2.1300
52-week range1.3600 - 9.7600
Volume85,651
Avg. volume1,173,679
Market cap93.227M
Beta (5Y monthly)1.43
PE ratio (TTM)N/A
EPS (TTM)-0.9800
Earnings date15 Nov 2021 - 19 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.52
  • GlobeNewswire

    Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards

    LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced that the Nasdaq Stock Market (“Nasdaq”) has confirmed to Acasti that the Company has regained compliance with Nasdaq’s minimum bid price requirement. Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma, commented, “We are pleased to have regained compliance with the listing requirements for Nasdaq, and are

  • GlobeNewswire

    Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ

    LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that it will be presenting at the Oppenheimer Fall Healthcare Summit being held virtually September 20-23, 2021. Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma, is scheduled to present on Tuesday, September 21, 2021 at 2:05 PM Eastern Time. Management will also be participating in one-on-one meetings with qualified members of the i

  • GlobeNewswire

    Acasti Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

    LAVAL, Québec, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announced that Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually between September 13-15, 2021. Acasti’s presentation will be available on-demand to registered attendees via the conference platform beginning Monday, September 13, 2021, at 7:0